Quantitative Studies of Gastric Endocrine Cells in Patients Receiving Long-term Treatment with Omeprazole

References

• Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric acid secretion 'by blocking (H+ + K+)ATPase. Nature 1981; 290: 159–161
   PubMed Web of Science ®Google Scholar
• Wallmark B, Lorentzon P, Larsson H. The mechanism of action of omeprazole - a survey of its inhibitory actions in vitro. Scand J Gastroenterol 1985; 20(suppl 108)37–51
   Google Scholar
• Lorentzon P, Eklundh B, Brändström A, Wallmark B. The mechanism for inhibition of gastric (H+ K+) ATPase by omeprazole. Biochim Biophys Acta 1985; 817: 25–32
   PubMedGoogle Scholar
• Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumours in pernicious anemia. Gastroenterology 1985; 88: 638–648
   PubMed Web of Science ®Google Scholar
• Mignon M, Lehy T, Bonnefond A, Ruszniewski P, Labeille D, Bonfils S. Development of gastric argyrophil carcinoid tumours in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer 1987; 59: 1959–1962
   PubMed Web of Science ®Google Scholar
• Allen J M, Bishop A E, Daly M J, et al. Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach. Gastroenterology 1986; 90: 970–977
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W, Stöckmann F, Conlon J M, Fölsch U R, Bonatz G, Wülfrath M. Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986; 35(suppl 1)84–97
   PubMed Web of Science ®Google Scholar
• Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(suppl 108)53–69
   Google Scholar
• Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35(suppl 1)42–55
   PubMed Web of Science ®Google Scholar
• Prichard P J, Yeomans N D, Mihaly G W, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64–69
   PubMed Web of Science ®Google Scholar
• Cederberg C, Ekenved G, Lind T, Olbe E. Acid inhibitory characteristics of omeprazole in man. Scand J Gastroenterol 1985; 20(suppl 108)105–112
   Google Scholar
• Dammann H G, Walter T A, Müller P, Simon B. Intragastric acidity under 28-day omeprazole treatment. Hepatogastroenterology 1985; 32: 191–194
   PubMedGoogle Scholar
• Mayer G, Arnold R, Feurle G, et al. Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol 1974; 9: 703–710
   PubMed Web of Science ®Google Scholar
• Grimelius L. A Silver nitrate stain for α2 cells in human pancreatic islets. Acta Soc Med Upsal 1968; 73: 243–270
   PubMedGoogle Scholar
• Lamberts R, Creutzfeldt W, Stöckmann F, Jacubaschke U, Maas S, Brunner G. Long-term omeprazole treatment in man, effects on gastric endocrine cell-population. Digestion 1988; 39: 126–135
   PubMed Web of Science ®Google Scholar
• Larsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastric enterochromaffin like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391–399
   PubMed Web of Science ®Google Scholar
• Arnold R, Hülst M V, Neuhof C H, Schwarting H, Becker H D, Creutzfeldt W. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 1982; 23: 285–291
   PubMed Web of Science ®Google Scholar
• Gustavsson S, Mårdh S, Norberg L, Nyrén O, Wallert S. Omeprazole, cimetidine, and ranitidine, Inhibition of acid production in isolated human parietal cells. Scand J Gastroenterol 1985; 20: 917–921
   PubMed Web of Science ®Google Scholar
• Håkanson R, Ekelund M, Sundler F. Activation and proliferation of gastric endocrine cells. Evolution and tumour pathology of the neuroendocrine system, S Falkmer, R Hakanson, F Sundler. Elsevier, Amsterdam 1984; 371–398
   Google Scholar
• Poynter D, Pick C R, Harcourt R A, et al. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut 1985; 26: 1284–1295
   PubMed Web of Science ®Google Scholar
• Lattes R, Grossi C. Carcinoid tumours of stomach. Cancer 1956; 9: 698–711
   PubMed Web of Science ®Google Scholar
• Carney J A, Go V LW, Fairbanks V F, et al. The syndrome of gastric argyrophil carcinoid tumours and non antral gastric atrophy. Ann Intern Med 1983; 99: 761–766
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G, Andersen B N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21: 357–363
   PubMed Web of Science ®Google Scholar
• Bordi C, Pilato F, Carfagna G, et al. Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis. Digestion 1986; 35(suppl 1)130–143
   PubMedGoogle Scholar
• Borch K, Renvall H, Liedberg G. Endocrine cell proliferation and carcinoid development, A review of new aspects of hypergastrinaemic atrophic gastritis. Digestion 1986; 35(suppl 1)106–115
   PubMedGoogle Scholar
• Bardram L, Thomsen P, Stadil F. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome. Digestion 1986; 35(suppll)116–122
   PubMedGoogle Scholar
• Arnold R, Koop H, Schwarting H, Tuch K, Willemer B. Effect of acid inhibition on gastric endocrine cells. Scand J Gastroenterol 1986; 21(suppl 125)14–19
   Google Scholar
• Shimoda T, Tanoue S, Ikegami M, et al. A histo-pathological study of diffuse hyperplasia of gastric argyrophil cells. Acta Pathol Jpn 1983; 33: 1259–1267
   PubMedGoogle Scholar
• Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988; 39: 61–79
   PubMed Web of Science ®Google Scholar